The Wellcome Trust is one of the world's largest charitable foundations dedicated to funding biomedical research. Based in the UK, it supports research across a wide range of health challenges, including neurodegenerative diseases.
Founded in 1936, the Wellcome Trust provides funding for researchers globally, with a focus on advancing understanding of health and disease. The Trust funds both fundamental science and translational research initiatives.
Wellcome supports significant research into neurodegenerative diseases:
¶ Major Grants and Initiatives
Wellcome has funded several major neurodegeneration research programs:
- Wellcome Centre for Cell Biology: research on protein aggregation mechanisms
- Wellcome Trust Sanger Institute: genetic studies of neurodegenerative diseases
- Senior Investigator Awards: supporting leading researchers in the field
- Discovery Awards: funding high-risk, high-reward research
Wellcome has funded key PSP research:
- Neuropathology studies of tau pathology distribution
- Genetic analysis of PSP cases
- Clinical phenotyping and biomarker studies
- Translational research on therapeutic targets
Key Wellcome funding schemes:
- Investigator Awards: Supporting established research leaders
- Senior Research Fellowships: Developing future research leaders
- Discovery Award: Funding innovative ideas
- Collaborative Awards: Supporting team science
Wellcome-funded research has contributed to:
- Understanding of protein aggregation in neurodegeneration
- Development of novel biomarkers
- Identification of genetic risk factors
- Training of next-generation neuroscientists